Document 0877 DOCN M9650877 TI Isolation of anti-HIV-1 lignans from Larrea tridentata by counter-current chromatography. DT 9605 AU Gnabre JN; Ito Y; Ma Y; Huang RC; Department of Biology, Johns Hopkins University, Baltimore, MD; 21218-2685, USA. SO J Chromatogr A. 1996 Jan 8;719(2):353-64. Unique Identifier : AIDSLINE MED/96155178 AB Several lignans, mostly new, were isolated from Larrea tridentata by assay-guided counter-current chromatography (CCC). Using the secreted alkaline phosphatase bioassay of HIV Tat transactivation and the two-phase hexane-ethyl acetate-methanol-water solvent system, two major components (Gr and Lo) were identified as anti-HIV active principles. The chemical structures of the constituents of Gr (G1-G4) and Lo (L1-L4) were determined by GC-MS and NMR. After optimization of isolation conditions, a large-scale isolation with the chloroform-methanol-water system yielded five constituents (FB1-FB5). The most predominant anti-HIV compound FB2 (denoted Malachi 4:5-6 or mal.4), which occurs in 0.23% yield, was separated from its FB1 isomer (0.13% yield). Compound FB4 and two tricyclic lignans (FB3 and FB5) were also isolated in a substantial amount for further testing of their anti-HIV activities. These compounds may represent a new class of anti-HIV agents with important clinical relevance. DE Antiviral Agents/*ISOLATION & PURIF/PHARMACOLOGY Chromatography, Thin Layer/*METHODS Gene Products, tat/PHYSIOLOGY HIV-1/*DRUG EFFECTS Lignans/*ISOLATION & PURIF/PHARMACOLOGY Mass Fragmentography Nuclear Magnetic Resonance Pilot Projects Plants, Medicinal/*CHEMISTRY Support, Non-U.S. Gov't Support, U.S. Gov't, Non-P.H.S. Support, U.S. Gov't, P.H.S. Trans-Activation (Genetics)/PHYSIOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).